This report presents a cost analysis of Bio-Adipic Acid production from glucose syrup. The process examined is a two-step catalytic process similar to Rennovia process. In this process, glucose is first oxidized to produce glucaric acid, which is then hydrogenated to produce Adipic Acid. The process uses a 70 wt% glucose-water syrup as raw material. This report examines one-time costs associated with the construction of a United States-based plant and the continuing costs associated with the daily operation of such a plant. More specifically, it discusses: * Capital Investment, broken down by: - Total fixed capital required, divided in production unit (ISBL); infrastructure (OSBL) and contingency - Alternative perspective on the total fixed capital, divided in direct costs, indirect costs and contingency - Working capital and costs incurred during industrial plant commissioning and start-up * Production cost, broken down by: - Manufacturing variable costs (raw materials, utilities) - Manufacturing fixed costs (maintenance costs, operating charges, plant overhead, local taxes and insurance) - Depreciation and corporate overhead costs * Raw materials consumption, products generation and labor requirements * Process block flow diagram and description of industrial site installations (production unit and infrastructure) This report was developed based essentially on the following reference(s): US Patent 8669397, issued to Rennovia in 2014 Keywords: Bioadipic Acid, Hexanedioic Acid, Dextrose, Glucose Oxidation, Glucaric Acid Hydrogenation, Green Adipic Acid, Renewable Feedstock